答案已發布9 來源
METiS TechBio香港IPO爆升：AI藥物「納米火箭」公司上市首日飆逾170%
METiS TechBio以每股10.50港元上市，集資約21.1億港元（約2.7億美元），首日開市報28.68港元，較招股價高約173%。[2][10] 公司利用人工智能設計納米材料藥物輸送系統，被形容為可把藥物精準送到細胞的「納米火箭」。[1][10] 香港AI生科IPO熱潮升溫，已有超過10間仍未盈利的生物科技公司申請上市，反映市場對AI醫藥平台的投資興趣上升。[20]
8.3K0
AI 提示
openai.comCreate a landscape editorial hero image for this Studio Global article: What should investors know about METiS TechBio’s Hong Kong IPO debut, including how much its shares surged, how much money the company raise. Article summary: METiS TechBio’s Hong Kong debut was a hot AI-biotech IPO: its shares opened 173.14% above the HK$10.50 offer price at HK$28.68, while some reports said the stock rose as much as 185% intraday. The company raised about HK. Topic tags: general, general web. Reference image context from search candidates: Reference image 1: visual subject "On April 19, Metis TechBio (stylized as “METiS TechBio”) announced that it had cleared its listing hearing at Hong Kong Exchanges and Clearing (HKEX), a key step toward a Hong Kong" source context "Metis TechBio clears key listing hurdle with AI nanodelivery focus" Reference image 2: visual subject "Founded in 2020, Metis uses a
METiS TechBio在香港交易所上市首日表現火熱，成為2026年最受關注的AI生物科技IPO之一。這間主打人工智能藥物輸送技術的初創企業，在首次公開招股（IPO）中集資約 21.1億港元（約2.7億美元），上市首日股價即大幅飆升。 [2][
10]
市場普遍認為，這次IPO反映投資者對 AI結合醫藥研發 的興趣正在快速升溫。
上市首日股價爆升
METiS TechBio的招股價為 每股10.50港元，公司共發行約 2.01億股，合共集資約21.1億港元。 [10]
股份在港交所掛牌後，開市價報 28.68港元，比招股價高出 173%；盤中升幅一度擴大至 約185%。 [2][
12]
這次上市採用港交所 第18C章（Specialist Technology Companies） 的規則框架，允許仍未盈利、但具備高科技潛力的公司上市集資。 [9]
Studio Global AI
Search, cite, and publish your own answer
Use this topic as a starting point for a fresh source-backed answer, then compare citations before you share it.
重點
- METiS TechBio以每股10.50港元上市，集資約21.1億港元（約2.7億美元），首日開市報28.68港元，較招股價高約173%。[2][10]
- 公司利用人工智能設計納米材料藥物輸送系統，被形容為可把藥物精準送到細胞的「納米火箭」。[1][10]
- 香港AI生科IPO熱潮升溫，已有超過10間仍未盈利的生物科技公司申請上市，反映市場對AI醫藥平台的投資興趣上升。[20]
人們還問
「METiS TechBio香港IPO爆升：AI藥物「納米火箭」公司上市首日飆逾170%」的簡短答案是什麼？
METiS TechBio以每股10.50港元上市，集資約21.1億港元（約2.7億美元），首日開市報28.68港元，較招股價高約173%。[2][10]
首先要驗證的關鍵點是什麼？
METiS TechBio以每股10.50港元上市，集資約21.1億港元（約2.7億美元），首日開市報28.68港元，較招股價高約173%。[2][10] 公司利用人工智能設計納米材料藥物輸送系統，被形容為可把藥物精準送到細胞的「納米火箭」。[1][10]
接下來在實務上我該做什麼？
香港AI生科IPO熱潮升溫，已有超過10間仍未盈利的生物科技公司申請上市，反映市場對AI醫藥平台的投資興趣上升。[20]
接下來我應該探索哪個相關主題？
繼續“中國灰色市場「影子 API」：開發者點樣繞過限制用到 Claude、Gemini 同 ChatGPT”以獲得另一個角度和額外的引用。
開啟相關頁面我應該將其與什麼進行比較？
對照「中國六座電動SUV爆紅：高端電動車市場新戰場」交叉檢查此答案。
開啟相關頁面繼續你的研究
來源
- [1] AI Drug Delivery Startup Metis Clears Hong Kong IPO Hurdlecaixinglobal.com
AI Drug Delivery Startup Metis Clears Hong Kong IPO Hurdle ... Founded in 2020, Metis uses artificial intelligence to address complex drug delivery challenges, particularly in the development of lipid nanoparticle systems Chinese AI-driven drug delivery sta...
- [2] AI drug-delivery developer Metis shares jump after Hong Kong IPOchinadaily.com.cn
AI drug-delivery developer Metis shares jump after Hong Kong IPO By Li Jing chinadaily.com.cn Updated: 2026-05-13 13:17 ... Shares of Chinese AI drug-delivery developer Metis TechBio Co Ltd opened at HK$28.68, up 173.14 percent from its IPO price on its tra...
- [8] IPO- Company Informationetnet.com.hk
METIS TECHBIO-P Listing Date 2026/05/13 Listed Today -- -- Listing Price 10.500 - Subscription Rate6,910.96x - Guarantee One Lot Size800 lot - One Lot Success Rate0.14% ... Metis TechBio Co. is a pioneer in AI-empowered nanomaterial innovation, dedicated to...
- [9] O'Melveny Advises on First IPO of an AI Nano-Delivery Company in ...omm.com
O’Melveny Advises on First IPO of an AI Nano-Delivery Company in US$270 Million Hong Kong Chapter 18C Listing of Metis TechBiohBMay 13, 2026 ... HONG KONG—May 13, 2026— O’Melveny represented joint sponsors and other underwriters in the initial public offeri...
